← Open Payments lookup

LAUREN BEASLEY: Open Payments

NPI 1578183802 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$811 in 44 payments from 11 companies in 2025. Trend: 2023 $694 · 2024 $1,020 · 2025 $811

Food & beverage: $811
CompanyPaymentsAmount
Boston Scientific Corporation15$220
Novartis Pharmaceuticals Corporation6$144
AstraZeneca Pharmaceuticals LP5$91
Amgen Inc.5$88
Merck Sharp & Dohme LLC3$85
BridgeBio Pharma, Inc.2$49
E.R. Squibb & Sons, L.L.C.3$44
PFIZER INC.2$35
AngioDynamics, Inc.1$20
Esperion Therapeutics, Inc.1$20

Products named: LEQVIO, WAINUA, Repatha, VERQUVO, CDS - MCT/CEM Monitoring, Attruby, ACCOLADE SR, VYNDAQEL.

Industry payments across MS — which companies pay providers there.